We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results:1-10 of 39

Employee’s Failure to Engage in Interactive Process to Address His Use of Opioids Dooms His ADA Claims
  • Jackson Lewis PC
  • USA
  • March 2 2018

An employee who refused to stop using morphine and would not engage in the interactive process with his employer could not survive summary judgment on


What’s At Stake for Medical Professionals In ‘Pill Mill’ Cases
  • Burr & Forman LLP
  • USA
  • November 28 2017

In Part One of this series, I detailed how the U.S. Department of Justice has focused its attention on the aggressive investigation and prosecution of


In the Matter of Wesley Pope, M.D.
  • Quarles & Brady LLP
  • USA
  • March 26 2017

An Oklahoma doctor wrote 19 Schedule II controlled substance prescriptions for a patient with low back pain over eight months without thoroughly


Coroner's Corner - Inquest into the death of 'ES'
  • Barry.Nilsson. Lawyers
  • Australia
  • February 23 2017

"The Angel of Death" - Elderly woman dies after fatal dose of morphine administered by family friend.ES (“Betty”) was aged 87 and had been suffering


GP disciplined for inappropriate and illegal prescribing practices
  • Buddle Findlay
  • New Zealand
  • May 30 2012

A GP who breached the Misuse of Drugs Act 1975 by prescribing a controlled drug (morphine) to a patient who he knew was dependent, and who prescribed opioids and benzodiazepines to a number of patients in circumstances that deviated significantly from the practice of his medical peers, has been found guilty of professional misconduct.


More power to prescribe controlled drugs for independent prescribers
  • Mills & Reeve LLP
  • United Kingdom
  • May 21 2012

There have been recent changes to the Misuse of Drugs Regulations 2001, which will mean appropriately qualified nurses and pharmacists will be able to prescribe controlled drugs, like morphine, diamorphine and prescription strength co-codamol.


Wiggins v Racing Queensland Limited 2011 QCAT 370
  • McInnes Wilson Lawyers
  • Australia
  • October 3 2011

On 9 August 2011 the Queensland Civil and Administrative Tribunal (QCAT) handed down its decision in the matter of Wiggins v Racing Queensland Limited 2011 QCAT 370.


OFT revisits morphine market to test effects of 2001 Napp ruling
  • Squire Patton Boggs
  • United Kingdom
  • July 6 2011

The OFT has found that competition has increased in the sustained release morphine market, ten years after it imposed restrictions and a landmark fine (the OFT’s first under Chapter II of the Competition Act 1998) on Napp Pharmaceuticals (Napp).


Understanding the new washington state pain medication and opioid rules
  • Lane Powell PC
  • USA
  • June 21 2011

The state of Washington has recently adopted new rules, or “standards of practice,” relating to pain management that apply to all physicians within the state.


OFT finds Napp case had a significant market impact
  • Nabarro LLP
  • United Kingdom
  • June 17 2011

The Office of Fair Trading (OFT) has carried out an evaluation of its abuse of dominance decision in the Napp Pharmaceuticals case (Napp) and found that it had a considerable impact on the market for sustained release morphine (SRM) tablets in the UK.